---
figid: PMC9097439__12964_2022_869_Fig2_HTML
figtitle: Regulatory role of short-chain fatty acids in inflammatory bowel disease
organisms:
- Hordeum vulgare
- Cinnamomum verum
- Beta vulgaris subsp. vulgaris
- Cyamopsis tetragonoloba
- Lactococcus lactis
- Faecalibacterium prausnitzii
- Roseburia hominis
- Homo sapiens
- Mus musculus
- gut metagenome
pmcid: PMC9097439
filename: 12964_2022_869_Fig2_HTML.jpg
figlink: /pmc/articles/PMC9097439/figure/Fig2/
number: F2
caption: Short-chain fatty acids (SCFAs) inhibit the progression of inflammatory bowel
  disease (IBD) by regulating innate immune sensors Toll-like receptors (TLRs) and
  nucleotide-binding and oligomerization domain-like receptor family pyrin domain-containing
  3 (NLRP3) inflam-masomes and play a role in inhibiting the progression of IBD. SCFAs
  not only inhibit TLR sig-naling but also inhibit TLR4 expression by suppressing
  the histone acetylation pathway. SCFAs also prevent the progression of IBD by regulating
  the assembly and attenuation of NLRP3 in-flammasomes. The Figures in this review
  were created with BioRender.com
papertitle: Regulatory role of short-chain fatty acids in inflammatory bowel disease.
reftext: Zhilin Zhang, et al. Cell Commun Signal. 2022;20:64.
year: '2022'
doi: 10.1186/s12964-022-00869-5
journal_title: 'Cell Communication and Signaling : CCS'
journal_nlm_ta: Cell Commun Signal
publisher_name: BioMed Central
keywords: Inflammatory bowel disease | Immunomodulating activity | Therapeutic effects
  | Short-chain fatty acids | Gut microbiota
automl_pathway: 0.9527939
figid_alias: PMC9097439__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC9097439__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9097439__12964_2022_869_Fig2_HTML.html
  '@type': Dataset
  description: Short-chain fatty acids (SCFAs) inhibit the progression of inflammatory
    bowel disease (IBD) by regulating innate immune sensors Toll-like receptors (TLRs)
    and nucleotide-binding and oligomerization domain-like receptor family pyrin domain-containing
    3 (NLRP3) inflam-masomes and play a role in inhibiting the progression of IBD.
    SCFAs not only inhibit TLR sig-naling but also inhibit TLR4 expression by suppressing
    the histone acetylation pathway. SCFAs also prevent the progression of IBD by
    regulating the assembly and attenuation of NLRP3 in-flammasomes. The Figures in
    this review were created with BioRender.com
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tlr2
  - Tlr4
  - Myd88
  - Irak1
  - Irak4
  - Traf6
  - Nfkb1
  - Jun
  - Ffar2
  - Hcar2
  - oh
  - Pycard
  - Nlrp3
  - Il13
  - TLR2
  - TLR4
  - MYD88
  - IRAK1
  - IRAK4
  - TRAF6
  - NFKB1
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - FFAR2
  - HCAR2
  - STS
  - PYCARD
  - NLRP3
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - IL13
---
